您要查找的是不是：
- A組B-溶血性鏈球菌group A B-haemolytic streptococci
- 目的探索抗DNA酶B測定A組溶血性鏈球菌（GAS）感染血清學(xué)方法的診斷價(jià)值。Objective To evaluate diagnostic value of anti DNase B microtitration in group A streptococcal (GAS) infection.
- A組β-溶血性鏈球菌GABHS; group A β-haemolytic streptococci
- 與β溶血性鏈球菌，鏈44球菌性肺炎及血型A有關(guān)的M抗原，M抗原M antigen(β-hemolytic streptococci, Streptococcus pneumoniae, and blood group A)
- 前置路由組是路由組B。The predecessor is routing group B.
- 方法雄性Wistar大鼠42只,隨機分為3組B組為腦死亡大鼠供肝移植組,G組為甘氨酸防護組,S組為士的寧拮抗組。Methods 42 male Wistar rats were randomized into 3 groups of liver transplantation: brain dead donor (BDD) group (group B), glycine pretreatment group with BDD (group G), strychnine pretreatment group with BDD (group S).
- 因此,郵件傳輸到路由組B中的橋頭服務(wù)器。Therefore, the message is transferred to the bridgehead server in routing group B.
- A組乙型溶血性鏈球菌group A of Streptococcus
- b組為HZ-2(會(huì )澤)和CYA(姚安縣); 其余的為a組。the b were grouped into HZ-2 and CYA,and other of the samples were the a group.
- 溶血性鏈球菌haemolytic streptococcus
- 女子A組其他拳術(shù)Female Group A Other Quanshu
- 扁桃腺炎:為炎癥性感染,通常由溶血性鏈球菌或病毒引起。"Tonsillitis: Inflammatory infection of the tonsils, usually with hemolytic streptococci or viruses."
- A組 9例采用NVB +DDP +YH 16方案 ,B組 9例選用NP方案。Group A ( n =9) received YH 16 combined with NP plan. Group B ( n =9) received NP regimen.
- 方法 :A組服用MMF ,B組服用硫唑嘌呤。 2組均服強的松。Methods:MMF was administered in group A,and AZT in group B.Prednisone was administered in both groups.
- 扁桃腺炎:為炎癥性感染，通常由溶血性鏈球菌或病毒引起。"Tonsillitis: Inflammatory infection of the tonsils, usually with hemolytic streptococci or viruses."
- VAS評分4組各時(shí)點(diǎn)均成漸進(jìn)性升高A組
- 丹毒由一種溶血性鏈球菌引起的皮膚或皮下組織突發(fā)性疾病，其癥狀是局部發(fā)炎和發(fā)燒An acute disease of the skin and subcutaneous tissue caused by a species of hemolytic streptococcus and marked by localized inflammation and fever.
- A組料蛋比和C組接近(2.43:1和2.42:1),均優(yōu)于B組(2.63:1)。FRC of group A was similar to that of group C(2.43vs.2.42),both superior to group B(2.63:1).
- α-溶血性鏈球菌Alpha-Hemolytic streptococcus
- 不良反應:A組呼吸困難明顯少于B、C組,有顯著(zhù)性差異(P<0.05)。For the adverse reactions, the dyspnea in Group A was absolutely less than that in Group B and C and the differences were obvious (P<0.05).
